SCHEMBL7404246

SCHEMBL7404246

COc1ccc(C(=C(Cc2ccc3c(c2)OOC3)C(=O)O)c2ccc(OC)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 2/20 0.42
NPC1 O15118 4/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 1/20 0.38
PTGS1 P23219 1/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
EDNRA P25101 1/20 0.38
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
CTBP2 P56545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7404248 0.81 EDNRB (0.61) EDNRBNPC1LMNARAB9ASMN1; SMN2
SCHEMBL4673253 0.75 ALDH1A1 (0.36) NPC1LMNAHTTRAB9ASMN1; SMN2
SCHEMBL10603224 0.74 USP2 (0.54) NPC1HTTRAB9ASMN1; SMN2L3MBTL1
SCHEMBL10606501 0.73 PLAU (0.56) NPC1RAB9ASMN1; SMN2L3MBTL1MAPT
SCHEMBL10619726 0.71 ALDH1A1 (0.40) NPC1LMNAHTTRAB9ASMN1; SMN2
SCHEMBL7401360 0.70 ALDH1A1 (0.60) EDNRBNPC1LMNARAB9ASMN1; SMN2
SCHEMBL345281 0.68 CA1 (0.55) NPC1LMNARAB9ASMN1; SMN2HPGD
SCHEMBL6059109 0.67 CYP3A4 (0.35) NPC1LMNAHTTRAB9ASMN1; SMN2
SCHEMBL7399206 0.67 ALDH1A1 (0.66) EDNRBNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL9179233 0.66 PDE4B (0.58) NPC1HTTRAB9AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0650484-A1 ENDOTHELIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1995-05-03 EP claimed
WO-1994002474-A1 ENDOTHELIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-02-03 WO claimed